HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart.

Abstract
Heart failure is a cause of significant morbidity and mortality in developed nations, and results from a complex interplay between genetic and environmental factors. To discover gene regulatory networks underlying heart failure, we analyzed DNA microarray data based on left ventricular free-wall myocardium from 59 failing (32 ischemic cardiomyopathy, 27 idiopathic dilated cardiomyopathy) and 33 non-failing explanted human hearts from the Cardiogenomics Consortium. In particular, we sought to investigate cardiac gene expression changes at the level of individual genes, as well as biological pathways which contain groups of functionally related genes. Utilizing a combination of computational techniques, including Comparative Marker Selection and Gene Set Enrichment Analysis, we identified a subset of downstream gene targets of the master mitochondrial transcriptional regulator, peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha), whose expression is collectively decreased in failing human hearts. We also observed decreased expression of the key PGC-1alpha regulatory partner, estrogen-related receptor alpha (ERRalpha), as well as ERRalpha target genes which may participate in the downregulation of mitochondrial metabolic capacity. Gene expression of the antiapoptotic Raf-1/extracellular signal-regulated kinase (ERK) pathway was decreased in failing hearts. Alterations in PGC-1alpha and ERRalpha target gene sets were significantly correlated with an important clinical parameter of disease severity - left ventricular ejection fraction, and were predictive of failing vs. non-failing phenotypes. Overall, our results implicate PGC-1alpha and ERRalpha in the pathophysiology of human heart failure, and define dynamic target gene sets sharing known interrelated regulatory mechanisms capable of contributing to the mitochondrial dysfunction characteristic of this disease process.
AuthorsSmita Sihag, Sharon Cresci, Allie Y Li, Carmen C Sucharov, John J Lehman
JournalJournal of molecular and cellular cardiology (J Mol Cell Cardiol) Vol. 46 Issue 2 Pg. 201-12 (Feb 2009) ISSN: 1095-8584 [Electronic] England
PMID19061896 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • ERRalpha estrogen-related receptor
  • Heat-Shock Proteins
  • PPARGC1A protein, human
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
  • Receptors, Estrogen
  • Transcription Factors
  • Proto-Oncogene Proteins c-raf
  • Extracellular Signal-Regulated MAP Kinases
Topics
  • Adolescent
  • Adult
  • Aged
  • Blotting, Western
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Down-Regulation
  • Extracellular Signal-Regulated MAP Kinases (genetics, metabolism)
  • Female
  • Heart Failure (genetics)
  • Heat-Shock Proteins (genetics, metabolism)
  • Humans
  • Infant
  • Linear Models
  • Male
  • Middle Aged
  • Mitochondria (genetics, metabolism)
  • Oligonucleotide Array Sequence Analysis
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
  • Proto-Oncogene Proteins c-raf (genetics, metabolism)
  • Receptors, Estrogen (genetics, metabolism)
  • Transcription Factors (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: